AZN

Peers: LLY MRK PFE ABBV JNJ NVS GSK BMY SNY AMGN

| Held by: PVAL AVDE DIHP DFIC PBPH PPH FVD DFAX BDYN IDEQ

Index	-
Market Cap	244.91B
Enterprise Value	272.26B
Income	10.45B
Sales	61.37B
Book/sh	32.43
Cash/sh	3.20
Dividend Est.	3.32 (2.10%)
Dividend TTM	3.23 (2.05%)
Dividend Ex-Date	Aug 07, 2026
Dividend Gr. 3/5Y	1.78% 3.25%
Payout	47.19%
Employees	96100
IPO	Oct 17, 2003

P/E	23.60
Forward P/E	13.72
PEG	1.16
P/S	3.99
P/B	4.87
P/C	49.30
P/FCF	22.53
EV/EBITDA	13.55
EV/Sales	4.44
Quick Ratio	0.67
Current Ratio	0.89
Debt/Eq	0.64
LT Debt/Eq	0.52
Option/Short	Yes / Yes

EPS (ttm)	6.69
EPS next Y	11.51
EPS next Q	2.62
EPS this Y	11.82%
EPS next Y	12.40%
EPS next 5Y	11.80%
EPS past 3/5Y	45.90% 22.05%
Sales past 3/5Y	9.82% 16.31%
EPS Y/Y TTM	25.90%
Sales Y/Y TTM	8.61%
EPS Q/Q	2.26%
Sales Q/Q	6.41%
Earnings	Jul 27 BMO
EPS/Sales Surpr.	5.98% -0.32%

Insider Own	3.59%
Insider Trans	-0.02%
Inst Own	60.87%
Inst Trans	-7.35%
ROA	9.15%
ROE	21.99%
ROIC	13.69%
Gross Margin	73.93%
Oper. Margin	22.38%
Profit Margin	17.02%
SMA20	-4.32%
SMA50	-9.53%
SMA200	-14.13%
Trades

Shs Outstand	1.55B
Shs Float	1.50B
Short Float	0.12%
Short Ratio	0.67
Short Interest	1.84M
52W High	212.71 -25.76%
52W Low	146.10 8.09%
Volatility	1.68% 2.02%
ATR (14)	4.30
RSI (14)	36.00
Beta	0.29
Rel Volume	1.04
Avg Volume	2.76M
Volume	766,994

Perf Week	-1.96%
Perf Month	-6.21%
Perf Quarter	-15.87%
Perf Half Y	-22.88%
Perf YTD	-10.02%
Perf Year	2.35%
Perf 3Y	11.59%
Perf 5Y	34.94%
Perf 10Y	134.13%
Recom	1.50
Target Price	215.75
Prev Close	158.50
Price	157.92
Change %	-0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-13-26	Downgrade	HSBC Securities	Buy → Hold

Aug-12-26 12:00AM	How AstraZenecas $400bn deal unravelled (Financial Times)
Aug-07-26 03:30PM	Roche Stock Jumps as Morgan Stanley Sees Drug Breakout (GuruFocus.com)
06:02AM	Significant demand for Revolution drug; Intellia pinpoints liver toxicity culprit (BioPharma Dive)
01:00AM	Why FTSE companies are heading for the exit (The Telegraph)
01:00AM	The 20-year exodus hollowing out the London stock market (The Telegraph)
01:00AM	Loading…
01:00AM	How the FTSE became a departure lounge for British companies (The Telegraph)
12:01AM	For Modernas Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off (The Daily Upside)
Aug-06-26 05:26AM	What the AstraZeneca-BMS rumors reveal about pharma megamergers (Pharma Voice)
Aug-05-26 12:17PM	AstraZeneca-Bristol Myers $400B Merger Buzz Cools After Report Denies Talks There Never Was A Deal To Be Done (Stocktwits)
10:01AM	AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation (InvestorsHub)
09:40AM	Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls (The Fly)
09:11AM	AstraZeneca and Bristol Myers Squibb merger talks denied (Quartz)
09:11AM	Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks (Quartz)
09:00AM	AZN spikes 6% after report it denies AstraZeneca-BMS merger talks (Investing.com)
08:10AM	AstraZeneca stock jumps and Bristol Myers shares fall on report of 'no discussions' (MarketWatch)
05:45AM	Loading…
05:45AM	SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics (Medical Device Network)
Aug-04-26 02:45PM	AstraZeneca Faces Fresh Pressure As $400B Bristol Myers Deal Talks Reportedly Persist (Stocktwits)
11:23AM	SOPH Stock Heads For Best Day In Over 8 Months Whats Driving Todays Super Rally? (Stocktwits)
10:32AM	Brokers split on AstraZeneca merger talk as shares recover some ground (Proactive)
06:15AM	SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies (PR Newswire)
05:30AM	How a pharma megamerger could squelch R&D (Axios)
Aug-03-26 09:46PM	Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today? (Stocktwits) -6.88%
04:29PM	AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks (GuruFocus.com)
04:26PM	Wall Street rallies, Dow closes at record on Iran talks optimism (Reuters)
01:27PM	AstraZeneca Eyes a Pharma Megamerger Nobody Asked For (Moby)
12:40PM	AstraZeneca Investors See Little Logic in Bristol Tie-Up (Bloomberg)
12:03PM	AstraZeneca shares slump after $400bn BMS merger rumours (Pharmaceutical Technology)
11:52AM	Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen? (Investing.com)
11:40AM	Astra Buying Bristol Makes No Sense, Fazeli Says (Bloomberg)
11:20AM	AstraZeneca slides after reports of Bristol Myers merger talks leave analysts 'perplexed' (CNBC TV)
09:27AM	Loading…
09:27AM	Bristol Myers Squibb Stock Jumps on Reported Merger Talks With AstraZeneca (Investopedia)
08:30AM	AstraZeneca stock sinks on reports of merger talks with Bristol Myers Squibb (Quartz)
08:26AM	AstraZeneca, Bristol Myers Squibb exploring merger talks (Quartz)
08:04AM	AstraZeneca Weighs a Deal Its CEO Said It Didn't Need (GuruFocus.com)
07:24AM	The gap between big tech and the rest of the market just vanished. Here's what it means for investors. (MarketWatch)
07:02AM	Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb (Proactive)
06:48AM	Palantir, Micron, SK Hynix, Alibaba, and More Stocks That Explain Today's Market (Barrons.com)
06:43AM	AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled. (MarketWatch)
05:54AM	Bristol Myers Squibb Stock Soars on Report of $400 Billion Merger Talks With AstraZeneca (Barrons.com)
03:24AM	AstraZeneca shares slide 7% on talks to buy Bristol Myers Squibb (Proactive)
02:17AM	FTSE 100 Live: London lagging as AstraZeneca offsets gains from oil drop (Proactive)
02:17AM	FTSE 100 Live: Blue-chips start down as AstraZeneca and oil giants sink (Proactive)
Aug-02-26 10:48PM	Biotech Stocks Need A Shot In The Arm After Brutal July: Could AstraZeneca-Bristol Myers Megadeal Be The Cure? (Stocktwits)
05:14PM	AstraZeneca slides 7% after report of merger talks with Bristol Myers Squibb (Investing.com)
04:20PM	AstraZeneca plots £300bn tie-up with US rival (The Telegraph)
Jul-30-26 05:12AM	How Telix landed a $2.1 billion radiopharma deal with Regeneron (Pharma Voice)
Jul-29-26 07:13AM	Earnings roundup: Biogens resiliency, AstraZenecas growth pitch and GSKs oncology push (BioPharma Dive)
Jul-28-26 01:41PM	AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales (GuruFocus.com)
09:32AM	AstraZeneca's drug pipeine is splitting opinion among City analysts (Proactive)
Jul-27-26 03:16PM	AstraZeneca's $2.63 Earnings Beat Supports $80 Billion Revenue Target (GuruFocus.com)
03:00PM	AstraZeneca PLC (AZN) Q2 2026 Earnings Call Highlights: Strong Oncology and Rare Disease Growth ... (GuruFocus.com)
01:04PM	US Futures Rise as Megacap Earnings and Fed Decision Headline Quarter's Busiest Week (GuruFocus.com)
12:25PM	AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst A Look At Some Key Highlights (Stocktwits)
11:26AM	AstraZeneca quarterly net profit rises 2% on strong cancer drug sales (Euronews)
07:56AM	AstraZeneca Q2 2026 earnings beat on cancer drug sales (Quartz)
07:52AM	Earnings live: AstraZeneca stock rises to kick off a busy earnings week (Yahoo Finance)
07:29AM	AstraZeneca profit rises on strong cancer drug sales (AFP)
02:43AM	AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE (Proactive)
02:43AM	AstraZeneca earnings beat forecasts despite slight revenue miss (Proactive)
02:16AM	FTSE 100 Live: Strong start expected to busy week as AstraZeneca, Vodafone report results (Proactive)
02:16AM	FTSE 100 Live: Stocks start higher as oil price tumbles, Vodafone and AstraZeneca impress (Proactive)
02:16AM	FTSE 100 Live: Stocks advance as oil price retreats, retail downturn eases (Proactive)
02:15AM	Astrazeneca: Q2 Earnings Snapshot (Associated Press)
Jul-24-26 09:15AM	AstraZeneca PLC (LSE:AZN) Q2 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
05:00AM	Novo escalates legal fight with Lilly; J&J reinforces dominance in multiple myeloma (BioPharma Dive)
Jul-22-26 10:50AM	Jefferies says September lung data can offset AstraZeneca trial failure (Proactive)
10:10AM	Trump Takes Another Swing at Drug Industry in Made-in-USA Push (Bloomberg)
Jul-17-26 06:31AM	MSD wins FDA approval for cholesterol pill to help plug Keytruda void (Pharmaceutical Technology)
Jul-15-26 08:49AM	After Crinetics' $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story? (FinanceWire)
06:00AM	Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million (Bloomberg)
05:18AM	J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals (BioPharma Dive)
Jul-14-26 11:14AM	AstraZeneca pays up to $1.5bn to license Dizal Pharmas lung cancer drug (Pharmaceutical Technology)
03:16AM	AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill (Proactive)
Jul-13-26 08:32AM	AstraZeneca Shares Slip After HSBC Cuts Rating Following Wainua Setback (AZN) (Investors Hub)
08:15AM	Biogen Stock Is Upgraded to Buy Ahead of Key Alzheimer's Drug Study Details (Barrons.com)
08:06AM	HSBC downgrades AstraZeneca after key trial failure (Proactive)
07:31AM	UBS stays positive on AstraZeneca ahead of second-quarter results (Proactive)
07:09AM	AstraZeneca stock dips as HSBC downgrades stock on tough path ahead (Investing.com)
02:19AM	FTSE 100 Live: Stocks search for direction as energy markets react to US-Iran strikes (Proactive)
02:19AM	FTSE 100 Live: Stocks flat as Trump says US to be 'guardian of Hormuz strait' (Proactive)
Jul-10-26 12:01AM	AstraZeneca Plunges After New Heart Disease Drug Fails Trial (The Daily Upside)
Jul-09-26 04:41PM	Stocks shrug off tensions to rise on renewed tech interest (AFP) -5.70%
03:39PM	Trending: Salesforce stock dips on Keybanc downgrade, AstraZeneca drug trial falls short (Yahoo Finance Video)
02:02PM	AstraZeneca Slides 9.9% After Heart Drug Trial Misses Late-Stage Goal (GuruFocus.com)
11:28AM	AstraZeneca and Ionis stocks drop significantly on Wainua ATTR-CM trial failure (Clinical Trials Arena)
11:27AM	AstraZeneca Gets a Rare Clinical Black Eye (Moby)
09:15AM	AstraZeneca's Wainua failure hurts credibility more than valuation, Jefferies warns (Proactive)
08:40AM	AstraZeneca Falls After Wainua Heart Disease Trial Fails (GuruFocus.com)
08:12AM	Nasdaq set to gain as chips in favor again, as oil rebounds (Proactive)
07:38AM	AstraZeneca Stock and Partner Ionis Sink After Trial Failure. Alnylam Soars. (Barrons.com)
07:14AM	AstraZeneca stock drops 9% after Wainua heart drug trial fails (Quartz)
07:11AM	IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years Retail Calls It Opportunity Of A Lifetime (Stocktwits)
06:35AM	Sino and AstraZeneca sign licence agreement for TQC3721 (Pharmaceutical Business Review)
06:00AM	Ionis Pharma dives on drug trial failure, and other early market movers (MarketWatch)
05:53AM	Major drugmaker loses $27 billion in market value after failed trial (MarketWatch)
04:43AM	AstraZeneca Shares Plunge on Rare Trial Failure of Heart Drug (Bloomberg)
03:50AM	AstraZeneca's £19bn blow as Wainua heart drug fails key late-stage trial (Proactive)
02:19AM	FTSE 100 Live: London index hit by AstraZeneca failure, Computacenter and Playtech soar (Proactive)
02:19AM	FTSE 100 Live: Index opens lower after AstraZeneca trial failure, Computacenter surges (Proactive)
Jul-08-26 07:58AM	AstraZeneca, GSK intensify China ties with Sino Biopharm deals (BioPharma Dive)

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

M.B.A.Mr. Pascal Claude Roland Soriot D.V.M.

CFO & Executive DirectorDr. Aradhana Sarin M.D.

EVP of Global opt. & ITMs. Pam P. Cheng

Head of Investor RelationsMr. Joris Silon

CHROMr. Jeffrey Pott J.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sharma Mani	See Remarks	May 20 '26	Sale	185.78	11,893	2,209,482	19,262	May 22 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Astrazeneca plc

Upgrade your Finviz experience